"ProteinQure empowers protein drug discovery teams using cutting-edge computational tools and help create novel therapeutics against challenging targets. We combine experimental methods along with state-of-the-art structure based algorithms, including molecular dynamics simulations and machine learning. We specialize in the design of novel protein scaffolds and libraries suitable for modern protein engineering display technologies. Combining high-accuracy biophysical models and high-throughput sequence search, we have generated massive libraries of protein binders enriched for desired structural and functional characteristics.
Currently, we are engaged in numerous commercial collaborations including top pharma companies such as AstraZeneca and Daiichi Sankyo.